Transdermal delivery of dopaminergic agentsRASCOL, Olivier.Neurology. 2005, Vol 65, Num 2, issn 0028-3878, 16 p., SUP1Serial Issue

Bromocriptine versus levodopa dans le traitement de première intention de la maladie de Parkinson. Premiers résultats à deux ans = Early treatment of Parkinson's disease with bromocriptine versus levopoda: first results after a 2 years follow upMONTASTRUC, J. L; RASCOL, O; RASCOL, A et al.Thérapie (Paris). 1988, Vol 43, Num 6, pp 461-463, issn 0040-5957Article

Flumarizine versus pizotifen: a double-blind study in the prophylaxis of migraineRASCOL, A; MONTASTRUC, J. L; RASCOL, O et al.Headache. 1986, Vol 26, Num 2, pp 83-85, issn 0017-8748Article

Arguments en faveur du traitement précoce de la maladie de Parkinson par les agonistes dopaminergiques = Arguments favoring early treatment of Parkinson's disease with dopaminergic agonistsRASCOL, O.Revue neurologique (Paris). 1999, Vol 155, Num 1, pp 35-42, issn 0035-3787Conference Paper

Thérapeutiques du stade précoce de la maladie de ParkinsonRASCOL, O.Revue neurologique (Paris). 2008, Vol 164, issn 0035-3787, F77-F84, HS2Conference Paper

Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patientsSABATINI, U; RASCOL, O; RASCOL, A et al.Clinical neuropharmacology. 1990, Vol 13, Num 3, pp 264-267, issn 0362-5664, 4 p.Article

Dyskinesia: L-dopa-induced and tardive dyskinesiaRASCOL, Olivier; FABRE, Nelly.Clinical neuropharmacology. 2001, Vol 24, Num 6, pp 313-323, issn 0362-5664Article

Le traitement médicamenteux des vertiges : Vertiges = Drug treatment of vertigoRASCOL, O; MONTASTRUC, J. L.La Revue du praticien (Paris). 1994, Vol 44, Num 3, pp 354-360, issn 0035-2640Article

INVESTIGATIONS COMPLEMENTAIRES DANS LES ACCIDENTS VASCULAIRES CEREBRAUXRASCOL A.1980; CHIRURGIE; ISSN 0001-4001; FRA; DA. 1980; VOL. 106; NO 7; PP. 487-490Article

L'évaluation du Plan de Déplacements Urbains d'Ile-de-France = Evaluation of the urban mobility plan of Ile-de-FranceDEBRINCAT, Laurence; RASCOL, Dominique.T.E.C. (Paris). 2008, Vol 199, pp 40-47, issn 0397-6513, 8 p.Article

A promising new technology for Parkinson's diseasePFEIFFER, Ronald F.Neurology. 2005, Vol 65, Num 2, pp S6-S10, issn 0028-3878, SUP1Article

Differential effects of M₁ and M₂ muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the ratRASCOL, O; LAMOUR, Y.Brain research. 1988, Vol 446, Num 2, pp 303-313, issn 0006-8993Article

Les noms valides des champignons = Valid names of fungiCHEVASSUT, G; RASCOL, J. P.1987, 75 p., isbn 2-907839-02-0Book

L'EXAMEN CYTOLOGIQUE DU LIQUIDE CEPHALO-RACHIDIEN DANS LES HEMORRAGIES MENINGEESRASCOL MM.1979; ARCH. ANAT. CYTOL. PATHOL.; FRA; DA. 1979; VOL. 27; NO 4; PP. 258-261; ABS. ENG; BIBL. 11 REF.Article

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's DiseasePEREZ-LLORET, Santiago; RASCOL, Olivier.CNS drugs. 2010, Vol 24, Num 11, pp 941-968, issn 1172-7047, 28 p.Article

Les benzodiazépines chez le sujet âgé = Benzodiazepines in elderlyRASCOL, O; ESCANDE, M.Gazette médicale de France (1969). 1986, Vol 93, Num 25, pp 59-63, issn 0016-5557Article

Medical treatment of levodopa-induced dyskinesiasRASCOL, O.Annals of neurology. 2000, Vol 47, Num 4, pp S179-S188, issn 0364-5134, SUP1Article

L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approachRASCOL, O.Movement disorders. 1999, Vol 14, pp 19-32, issn 0885-3185, SUP1Conference Paper

L'EXAMEN CYTOLOGIQUE DU LIQUIDE CEPHALO-RACHIDIEN DANS LES HEMORRAGIES MENINGEESRASCOL MM.1980; SEM. HOP.; FRA; DA. 1980; VOL. 56; NO 9-10; PP. 449-452; ABS. ENG; BIBL. 11 REF.Article

Enregistrement ambulatoire de la pression artérielle dans l'hypotension orthostatique de la maladie de Parkinson = Ambulatory recording of blood pressure in orthostatic hypotension of Parkinson's diseaseSENARD, J. M; RASCOL, O; CHAMONTIN, B et al.Revue neurologique (Paris). 1993, Vol 149, Num 10, pp 541-546, issn 0035-3787Conference Paper

Square wave jerks in Parkinsonian syndromesRASCOL, O; SABATINI, U; SIMONETTA-MOREAU et al.Journal of neurology, neurosurgery and psychiatry. 1991, Vol 54, Num 7, pp 599-602, issn 0022-3050Conference Paper

Does fluoxetine aggravate Parkinson's disease ? A pilot prospective studyMONTASTRUC, J.-L; FABRE, N; BLIN, O et al.Movement disorders. 1995, Vol 10, Num 3, pp 356-357, issn 0885-3185Conference Paper

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease : a five year follow upMONTASTRUC, J. L; RASCOL, O; SENARD, J. M et al.Journal of neurology, neurosurgery and psychiatry. 1994, Vol 57, Num 9, pp 1034-1038, issn 0022-3050Conference Paper

Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophyRASCOL, O. J; CLANET, M; SENARD, J. M et al.Advances in neurology. 1993, Vol 60, pp 395-397, issn 0091-3952Article

LA SCLEROSE EN PLAQUES. DE CHARCOT ET VULPIAN A NOS JOURSRASCOL A; CLANET M.1982; REVUE NEUROLOGIQUE; ISSN 0035-3787; FRA; DA. 1982; VOL. 138; NO 12; PP. 921-930; ABS. ENG; BIBL. 8 REF.Article